The Latest Analyst Ratings for Organogenesis Hldgs
Portfolio Pulse from Benzinga Insights
Over the last quarter, Organogenesis Hldgs (NASDAQ:ORGO) has received 2 bullish and 2 indifferent analyst ratings. The company's average 12-month price target is $5.5, representing a 26.67% decrease from the previous average price target of $7.50.
August 11, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Organogenesis Hldgs has received mixed analyst ratings over the last quarter, with an average 12-month price target of $5.5, a decrease from the previous target.
The decrease in the average 12-month price target for Organogenesis Hldgs indicates a less optimistic outlook from analysts, which could negatively impact the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100